Navigation Links
Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
Date:8/18/2009

Emeryville, Calif., Aug. 18 /PRNewswire/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).

Under the CRADA, the U.S. Naval Health Research Center will conduct comparative tests of Adamas' TCAD therapy against various strains of the influenza A virus, including seasonal influenza (H1N1, H3N2), avian influenza (H5N1) and novel influenza A/H1N1. The purpose of these studies is to assess the in vitro activity of TCAD therapy against various circulating and/or highly pathogenic strains of the influenza A virus, as well as to compare the in vitro activity of TCAD therapy to other pharmaceutical agents when used alone or in double combination. Data from these experiments will be used to advance the development of Adamas' TCAD therapy as a potential broad-spectrum antiviral therapy for serious infections caused by influenza A viruses. In addition, Adamas and the Navy's work with the novel influenza A/H1N1 virus may provide insight into this widespread public health issue.

"Collaborating with the U.S. Naval Health Research Center, with its leadership in medicine and its seminal work in discovering the novel influenza A/H1N1 virus, will significantly advance Adamas' efforts to develop TCAD therapy in response to the influenza pandemic," said Gregory Went, Ph.D., Chief Executive Officer and Chairman of Adamas. "We look forward to partnering with the Naval Health Research Center to generate d
'/>"/>

SOURCE Adamas Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
2. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
3. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
4. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
5. Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
6. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
7. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
8. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
9. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
10. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
11. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014  ProteinSimple announced today that it has launched ... assay allows users to detect all proteins separated in ... users can analyze proteins without the need for an ... protein analysis as we know it today. First, the Simple ... no messy gels, no transfer tanks, no blots, no ...
(Date:7/28/2014)... Germany and LONDON ... , Collaboration aims to create and commercialize ... guide the use of IRESSA  for non-small cell lung ... on QIAGEN,s FDA-approved  therascreen   EGFR test and is planned ... automated instruments  Project enabled by AstraZeneca master ...
(Date:7/28/2014)... 28, 2014 OmPrompt today ... to help it meet the global demand for ... and logistics. Albion joins Shackleton Ventures. ... Over the past 18 months OmPrompt has underpinned ... management team and its operations. The new funding ...
Breaking Medicine Technology:ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6OmPrompt Funded for Customer Automation Management Market Expansion 2
... GREEN BAY, Wis., Jan. 10, 2012  With increasing demands ... longer hours or shuttling the children to and from ... of a challenge. To make life simpler for shoppers ... its mobile pharmacy app, allowing users to quickly and ...
... Oramed Pharmaceuticals Inc. (OTCBB:ORMP) ( http://www.oramed.com ... today that it has filed a provisional patent application ... a combination therapy of its lead compound, ORMD-0801 in ... no such approved combination product available on the market ...
Cached Medicine Technology:Shopko Launches Mobile Pharmacy App to Maximize Customer Convenience 2Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes 2Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes 3
(Date:7/28/2014)... The Oakwood Foundation celebrated a major gift this ... PC that will benefit each community we serve for ... The HBWS group is among the Foundation’s largest physician ... donations. Through their latest gift, they will be one ... Classic for the next 6 years; provide state-of-the-art technology ...
(Date:7/28/2014)... meal you,ve ordered at a restaurantor when something ... your brain. , These waves are called ... cellsboth excitatory and inhibitoryplaying together in an orchestrated ... waves have been associated with higher-level brain function, ... to schizophrenia, Alzheimer,s disease, autism, epilepsy and other ...
(Date:7/28/2014)... By Amy Norton ... -- Tonsillectomies are commonly done to relieve sleep apnea in ... speed kids, weight gain -- especially if they,re already overweight. ... a risk factor for a range of health problems -- ... for kids who need it. Instead, they said, doctors ...
(Date:7/28/2014)... July 28, 2014 UT Southwestern Medical Center ... and irreversibly interferes with the activity of a ... tumors. , The molecule, SML-8-73-1 (SML), interferes with ... oncogene homolog. The gene produces proteins called K-Ras ... can result in normal cells dividing uncontrollably and ...
(Date:7/28/2014)... July 28, 2014 Lourdes Health System ... access and reduced wait times for veterans needing medical ... systems in the state—and the only one in Camden, ... Patient-Centered Community Care program (PC3). PC3 gives veterans access ... hospital cannot provide services due to lack of available ...
Breaking Medicine News(10 mins):Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 2Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 3Health News:UTSW cancer researchers identify irreversible inhibitor for KRAS gene mutation 2Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3
... coronary artery , THURSDAY, Feb. 11 (HealthDay News) -- Former ... Thursday evening in a New York City hospital after he ... , The 63-year-old Clinton, who underwent quadruple bypass surgery in ... reports. , "Today President Bill Clinton was admitted to ...
... , CHICAGO , Feb. 11 ... of Frank Corbett , founder of Frank J. Corbett , ... "Frank was a pioneer in our industry, a legend, a leader for ... CEO, Scott D. Cotherman . "His passion and drive for our industry ...
... , CHICAGO , Feb. 11 The ... proud to announce the selection of attorney Jeffrey Schlapp to ... ® and Chicago Magazine 02/2010 . , When it ... nursing home industry itself on behalf of the injured becomes a game-changer. ...
... children with asthma often recognize signs that their child is ... until the attack occurs, researchers at Washington University School of ... published in the Annals of Allergy, Asthma and Immunology, ... thus relieve a child,s symptoms, possibly reduce the extent of ...
... ... charity Landlife and is giving away free wild flower seeds. Simply request free samples from ... 1st April through until May. , ... (PRWEB) February 13, 2010 -- The online window blinds retailer, Tuiss.co.uk , has ...
... aren,t conclusive, researchers say , THURSDAY, Feb. 11 (HealthDay ... that eating dark chocolate appears to lower your risk of ... , But the findings, based on a review of ... is good for your heart. And dietitians say too much ...
Cached Medicine News:Health News:Ex-President Clinton Undergoes Heart Procedure 2Health News:Corbett Accel Healthcare Group Mourns Passing of Founder Frank J. Corbett 2Health News:Corbett Accel Healthcare Group Mourns Passing of Founder Frank J. Corbett 3Health News:Beware the Gentle Man With Unique Knowledge: The Passion and Skill of a Rising Star 2Health News:Parents often wait too long to treat children's asthma symptoms 2Health News:Parents often wait too long to treat children's asthma symptoms 3Health News:Go Wild with Blinds Retailer Tuiss.co.uk and Environmental Charity Landlife 2Health News:Dark Chocolate May Lower Stroke Risk 2
... The design of the Hi-Top ... to be held back in ... shoe counter. The front is ... and compression on the toes. ...
... semi-rigid post op shoe is ideal for ... breathable upper will keep your patient both ... closure provides even tension and compression. The ... support for your patient. The black TPR ...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: